Condition
Discal Sciatica
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
100%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
P 3 (2)
Trial Status
Unknown1
Terminated1
Clinical Trials (2)
Showing 2 of 2 trials
NCT02151045Phase 3UnknownPrimary
Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica
NCT01482897Phase 3TerminatedPrimary
Efficacy of corticoïd Infiltration Via Sacro-coccygien Hiatus in Discal Sciatica
Showing all 2 trials